Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.52 is 43% below its 5-year average of 2.65, near the low end of its 5-year range (1.21–9.36).
As of the fiscal period ended Tuesday, June 30, 2026. 1.31% below its 12-month average of 1.54.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.52.
CURRENT RATIO
1.52
CURRENT RATIO AVG TTM
1.54
CURRENT RATIO AVG 3Y
1.71
CURRENT RATIO AVG 5Y
2.65
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-1.31%
CURRENT VS 3Y AVG
-10.94%
CURRENT VS 5Y AVG
-42.61%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 532 covered companies
CURRENT VS SECTOR MEDIAN
-54.69%
vs the sector median at left
Eton Pharmaceuticals, Inc.
Market Cap
$1.52B
Current Ratio
1.52
TTM Avg
1.54
3Y Avg
1.71
5Y Avg
2.65
Market Cap
$1.47B
Current Ratio
18.31
TTM Avg
12.63
3Y Avg
8.12
5Y Avg
8.12
Market Cap
$1.47B
Current Ratio
3.02
TTM Avg
3.13
3Y Avg
2.94
5Y Avg
3.03
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Eton Pharmaceuticals, Inc. (ETON) | $1.52B | 1.52 | 1.54 | 1.71 | 2.65 |
| Innoviva, Inc. (INVA)vs › | $1.53B | 16.01 | 8.50 | 7.33 | 23.22 |
| GH Research PLC (GHRS)vs › | $1.51B | 28.70 | 25.68 | 28.23 | 39.79 |
| Certara, Inc. (CERT)vs › | $1.57B | 2.55 | 2.09 | 2.53 | 2.95 |
| Braveheart Bio, Inc. (BRVE)vs › | $1.48B | N/A | N/A | N/A | N/A |
| Maze Therapeutics, Inc. (MAZE)vs › | $1.47B | 18.31 | 12.63 | 8.12 | 8.12 |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.47B | 3.02 | 3.13 | 2.94 | 3.03 |
| AnaptysBio, Inc. (ANAB)vs › | $1.43B | 5.61 | 9.29 | 11.65 | 16.84 |
| Inhibrx Biosciences Inc. (INBX)vs › | $1.40B | 5.07 | 3.94 | 5.82 | 5.62 |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.65B | 2.91 | 2.71 | 3.12 | 3.05 |
Current Ratio
1.52
Quick Ratio
1.30
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 1.52 |
| 2026-03-31 | 1.21 |
| 2025-12-31 | 1.57 |
| 2025-09-30 | 1.63 |
| 2025-06-30 | 1.77 |
| 2025-03-31 | 1.97 |
| 2024-12-31 | 2.06 |
| 2024-09-30 | 1.51 |
| 2024-06-30 | 1.40 |
| 2024-03-31 | 1.59 |
| 2023-12-31 | 1.65 |
| 2023-09-30 | 2.61 |
| 2023-06-30 | 2.75 |
| 2023-03-31 | 2.55 |
| 2022-12-31 | 3.10 |
| 2022-09-30 | 3.52 |
| 2022-06-30 | 5.19 |
| 2022-03-31 | 5.39 |
| 2021-12-31 | 5.18 |
| 2021-09-30 | 4.83 |
| 2021-06-30 | 9.36 |
| 2021-03-31 | 9.46 |
| 2020-12-31 | 6.51 |
| 2020-09-30 | 3.04 |
| 2020-06-30 | 4.68 |
| 2020-03-31 | 7.48 |
| 2019-12-31 | 7.65 |
| 2019-09-30 | 10.94 |
| 2019-06-30 | 11.48 |
| 2019-03-31 | 5.89 |
| 2018-12-31 | 13.59 |
| 2018-09-30 | 5.68 |
| 2018-06-30 | 8.08 |
| 2018-03-31 | 11.99 |
| 2017-12-31 | 16.76 |
| 2017-09-30 | 0.00 |
| 2017-06-30 | 0.00 |
